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The known The documentation of appropriate treatment goals in patients with 
advanced stages of incurable disease remains both underutilised and poorly 
communicated. Several new end-of-life forms have been devised but with minimal 
research to support their impact. 
The new In a patient cohort with a substantial disease burden, the implementation 
of the new inclusive ‘goals-of-care’ strategy conferred limited quantitative 
advantages over the existing ad-hoc ‘not-for-resuscitation’ form. 
The implications Greater top-down governance and a cohesive, sustained clinical 
strategy is required before successful full implementation in substituting one end-
of-life form for another. 
Abstract 
Objective: Compare the clinical impact of two different health department sanctioned, 
end-of-life (EOL) documentation strategies. 
Design: An unblinded, pre-and-post, controlled study over two corresponding six-
month periods in 2016 and 2017 comparing the current ad-hoc not-for-resuscitation 
(NFR) with a new, inclusive goals-of-care (GOC) strategy supported with staff 
education.  
Setting and participants: Patients admitted to two medical and oncology wards in a 
large private hospital.  
Main outcome measures: The uptake of EOL forms per hospitalisation and the timing 
between hospital admission, EOL form completion, and in-patient death. Secondary 
outcomes included the utilisation of rapid response team (RRT), palliative and critical 
care services. 
Results: Across both study periods 1303 patients (NFR=650, GOC=653) underwent 
1,885 admissions (mean Charlson Score=3.7). Patients admitted during the GOC 
period had a higher uptake of EOL documentation (346 vs 150 EOL forms per 1000 
admissions, P<0.0001), a higher proportion of EOL forms completed within the first 
48-hours of admission (58 vs 39%, P=0.0002), but a higher incidence of altering the 
initial EOL level-of-care (P=0.003). All other measures including EOL documentation 
within 48-hours of death (P=0.50), activation of RRT (P=0.73), and admission to critical 
(P=0.62) or palliative (P=0.81) care services remained similar. Documentation of GOC 
forms was often incomplete with most sub-sections left blank between 74–87% of 
occasions. 
Conclusion: Despite an increased uptake of the GOC form, overall utilisation 
remained low, written completion was poor, and most quantitative outcomes remained 
statistically unchanged. Further research is required before a wider GOC 
implementation can be supported in private healthcare systems. 
 
  
Introduction 
Goals-of-Care (GOC) is a revised and holistic interpretation of an established, self-evident 
principle that aims to clearly discuss and document the extent to which medical care should 
be imparted on a patient, at any stage of their hospital journey. It weighs the likely burden 
and response of a given therapy against the severity of the disease process, a patient's life 
expectancy, quality-of-life and individual preferences. This most fundamental of all clinical 
decisions therefore delineates the direction for all subsequent healthcare and should be 
regarded as the cornerstone of any clinical management plan.  
Presently, with Western Australian Health Department of Health (WADoH) approval, 
selected hospitals are piloting the GOC on the basis it will be a more universally applicable, 
proactive concept amenable to an improved shared decision-making process. This contrasts 
the prevailing clinical practice that currently utilises the discretional "Not-for-Resuscitation” 
(NFR) order. The ad-hoc nature of NFR orders often relies on the unspoken assumption that 
healthcare providers intuitively understand the management priorities of any given patient, 
thus circumventing the need for detailed discussions until such time that a medical crisis 
mandates a reactive clinical intervention.  
Thus, for GOC to be an effective successor to the NFR it must be more than an alternative 
written document. Instead, it must be part of an overarching, senior clinician led, cultural 
change that re-focuses on earlier patient engagement and considers broader management 
strategies beyond cardio-pulmonary resuscitation status.  With this in mind, the aim of this 
study was to compare the utilisation and quantitative outcomes of an inclusive GOC against 
an ad-hoc NFR strategy in two dedicated oncology / general medical wards at a large 
Australian private hospital. 
Methods 
Setting  
This study was conducted over a six month period in a large 578 bed Western Australia 
private hospital, which also has a dedicated chemotherapy day suite and busy oncology 
service.  
Design  
A quasi-experimental pre-and-post controlled study design over two corresponding 6-month 
periods in 2016 and 2017 comparing the WADoH sanctioned NFR and GOC forms. Patients 
were eligible if they were 18-years or older and admitted to one of two predominately 
medical or oncology wards under the primary care of a physician, haematologist, palliative 
care physician or oncologist. These wards where specifically chosen because they incorporate 
healthcare disciplines with a higher burden of advanced disease states and frailty requiring a 
greater awareness of end-of-life (EOL) issues. Patients discharged alive within 48-hours of 
hospitalisation were excluded to avoid including short-term chemotherapy or procedural 
admissions. Patients on other wards, not involved in the study, all used the NFR form 
throughout the study period. All forms were valid for the current admission only with the 
study protocol mandating a separate form for any subsequent admission. Disease burden was 
compared using Charlson Comorbidity Scores.1  
The first six-month period (March – August 2016) was the control period and utilised the 
standard-of-practice NFR form (see Supplemental File 1 - NFR Form). The use of this form 
was discretionary for treating teams, only allowed physicians to define invasive limitations in 
therapy, and conformed with current state-wide WADoH practice. 
The second 6-month period (March – August 2017) was considered the intervention arm and 
investigated the implication of an inclusive four-treatment phase GOC form (see 
Supplemental File 2 – GOC Form) adapted from previous local and interstate concepts.2 
Treating senior clinicians were strongly encouraged, but not mandated, to complete a GOC 
form within 48-hours of hospitalisation for every patient admitted to the involved wards. The 
inclusive concept is consistent with a similar policy employed by the Tasmanian Government 
Department of Health and Human Services.3 The GOC form design differs fundamentally from 
the NFR form by delineating broad care pathways for individual patients, offering four 
treatment phases including full supportive management without limitations. The GOC had 
not been previously used in this institution. 
A six-month post intervention point prevalence study was conducted to assess ongoing 
uptake of the GOC form in March 2018. 
Ethics approval & trial registration 
Prior ethics approvals were granted from the StJOG Healthcare Human Research Ethics 
Committee (HREC #1070) and this trial is registered with the Australian New Zealand Clinical 
Trials Registry (http://www.ANZCTR.org.au/ACTRN12617000105347.aspx).  
Outcomes  
The main study outcomes were the uptake rates of both EOL (NFR and GOC) forms per 1000 
hospitalisations and the timing between hospital admission, EOL form completion, and 
patient death. Following local consultation, 48-hours was chosen as the cut-off time for EOL 
completion both after hospitalisation and before death to allow for adequate patient 
assessment at admission and preparation before death while maximising overall healthcare 
awareness of the desired treatment goal. 
Secondary outcomes included the utilisation of palliative and critical care services; the overall 
rapid response team (RRT) activation rate; the number of patients in whom a  EOL order was 
completed within 24-hours of a RRT activation;4,5 the number of times an EOL form was 
altered in the course of a single hospitalisation; and frequency at which NFR or GOC forms are 
completed outside normal office hours suggesting a less planned approach to patients EOL 
care. Finally, the researchers wanted to investigate the “surprise question” concept by 
following through all patients for a minimum 4-months post admission to the year’s end by 
using a censor date of 31st December 2016 (NFR Phase) and 2017 (GOC Phase) to compare in-
hospital EOL planning and form completion with subsequent short-term mortality.6 Extensive 
qualitative patient and clinical staff data was also collected but is the subject of a separate 
manuscript. 
Data collection 
All data was collected retrospectively at the completion of each study period by a single 
dedicated investigator with subsequent screening by a second investigator. Data was 
extracted from both electronic and hard copy inpatient hospital medical records using a pre-
formatted data extraction tool. 
Goals-of-care education and promotion 
Coinciding with the introduction of the GOC form (intervention arm) a series of educational 
activities and changes to the ward-rounds format were implemented to foster increased GOC 
uptake (see Supplementary File 3 – Supplementary Methodology).  
Community engagement 
This study benefited from the contributions supplied by the St John of God Healthcare 
Consumer Advisory Group to help formulate the context of the study and determine the 
optimal role of EOL documentation in our hospital.   
Statistical analysis 
Categorical variables were described in absolute numbers and percentages with comparisons 
performed using the chi-squared test. Continuous variables were described in mean, standard 
deviation, median and interquartile range with comparisons performed using the unpaired 
Student’s t-test for normally distributed data and the Mann–Whitney U test for non-
parametric continuous data. All analyses were performed by SPSS for Windows (Version 22.0, 
IBM Corp., Armonk, NY, USA) with a ‘P’ value < 0.05 taken as significant in this study. There 
were no missing patient files. Sample size calculations and other statistical methods can be 
found in Supplementary File 3 – Supplementary Methodology. 
Results 
Between the two corresponding six-month periods of March – August in 2016 and 2017 there 
were a total 1303 patients hospitalised on 1,885 occasions under 43 separate specialists (5 of 
whom attended 1-hour consultant designated education sessions). A total 538 EOL forms 
were generated across 477 admissions. The baseline characteristics of these phases is 
summarised in Table 1. Patients admitted under onco-haematology specialty teams (NFR = 
52.3%, GOC = 54.2%, P = 0.51) comprised the majority of patients in both cohorts. 
Consequently, the Charlson Comorbidity Index in both cohorts reflected a high burden of 
disease (NFR = 3.7, GOC = 3.7, P = 0.99).   
Table 2 displays the first main outcome of EOL uptake and designated level-of-care for each 
group with the GOC uptake significantly higher in all sections except for palliative level ward 
care (P = 0.77). The bottom half of Table 2 compares the association between EOL 
documentation and the polar treatment spectrums of RRT activation, intensive or coronary 
care admission and palliative care admission, plus subsequent hospital mortality. The 
differences in all these outcomes remained statistically non-significant. 
Table 3 is restricted to all hospitalisations where an EOL form was completed during the 
admission. While all specialties increased their uptake of the GOC form above the NFR form, 
it was the medical specialities where the increases were the greatest. The time relationship 
between admission and EOL documentation within 48-hours was a main outcome and 
occurred significantly more often in the GOC group (39.0 vs 58.1%, P = 0.0002) with a 
resultant increase in the rate of GOC level-of-care alteration during an admission (17.7 vs 41.4 
EOL alterations per 1000 admissions, P = 0.003). All other outcomes were not significantly 
influenced by the GOC. 
Table 4 compares the association between all patients who died in-hospital with the 
frequency and timing of EOL form completion. The main outcome of GOC completion within 
48-hours of death was not statistically significant between the two groups (29.5 vs 34.9%, P 
= 0.50). 
EOL uptake rates changed with time, increasing every two months during the GOC phase (NFR 
Mar-Aug 15.0%, GOC Mar-Apr 30.9%, GOC May-Jun 34.9%, GOC Jul-Aug 37.7%, P < 0.0001) 
before declining in a six-month post-GOC phase point prevalence study to 27.9% (12 of 43 
patients) with 41.7% (5 of 12) GOC completed with 48-hours of admission. 
Table 5 examines EOL completion in patients who died before the end of each corresponding 
year with a minimum 4-month follow up. The premise being, “Would the specialist doctor be 
surprised if any of these patients died by year’s end?” and thus initiated EOL discussions in 
advance. Short-term mortality was high (30.0%) but there was no statistical difference in the 
number of patients with EOL orders between the two groups. 
Supplementary eTable 1 displays the GOC form completion by sections. As the GOC level (A 
– D) only requires a “tick box” the desired accompanying information, important to 
understanding the decision rationale, was seldom documented with most sections left blank 
between 74–87% of occasions. 
Discussion 
With the advent of successful resuscitation techniques in the 1960s came the antipodal 
necessity to develop adequate do-not-resuscitation (DNR) orders. The GOC is the latest 
generation of DNR/EOL forms existing in comparable formats as the Universal Form of 
Treatment (UFOT) in the United Kingdom or Physician Orders for Life-Sustaining Treatment 
(POLST) in the United States of America.7,8 This is the largest Australian controlled study to 
examine a series of quantifiable outcomes following the introduction of a new GOC form. 
Preceded by an extensive educational and promotional programme, uptake of the new form 
was significantly higher than the preceding ad-hoc NFR form, but well below previously 
published uptake levels.7,9,10,11 Aside from a higher percentage of GOC being completed 
within the first 48-hours of hospital admission, there were no other desirable statistical or 
clinical changes in a series of measurable outcomes. 
Comparisons with previously published EOL literature is limited with the most influential work 
derived from the three-treatment phase UFOT form reported by Fritz et al in Cambridge.7 
Smaller in size (1,090 admissions) and with less comorbid disease (Charlson Score < 2.3), this 
control study demonstrated a substantially greater UFTO uptake rate (82%) with a 
corresponding reduction in harmful events in a cohort of medical patients. Most other 
international published controlled clinical GOC studies are restricted to dementia or nursing 
home patients.12,13 In Australia there have been a handful of small ward-based studies 
primarily concentrating on GOC completion rates (with reported uptakes between 82 – 90%)  
and form content,9,10,11 while Orford and colleagues have reported on improving EOL 
documentation at the medical crisis juncture of unplanned intensive care admission.14,15 It 
is on this limited clinical research that the GOC is now being deployed across a number of 
Australian states. This is important given that literature has also persistently demonstrated a 
discordance between patients at high-risk of dying, their family members and healthcare 
professionals regarding the communication and documentation of EOL preferences.16-21 
Furthermore, “Early discussions about goals-of-care are associated with better quality of life, 
reduced use of nonbeneficial medical care near death, enhanced goal-consistent care, positive 
family outcomes, and reduced costs”,20 with advanced care decision making for patients being 
regarded as an inherent component of good clinical practice, enshrined in Commonwealth 
healthcare policy (EQuIP 1, 9 & 12).23  
Despite a multifaceted and widespread educational campaign prior to the GOC (intervention) 
phase of this study, the uptake rate of GOC forms was limited (344.4 forms per 1000 
hospitalisations) and well below the rates reported in smaller studies.7,9,10,11 This was an 
unexpected result given that in the Australian private health care system most specialist 
doctors have a long and established continuity-of-care rapport with their patients, in theory 
making it easier to discuss the sensitive and time-consuming matter of therapy limitations 
than with the less continuant public healthcare system. The limited GOC uptake rates in our 
private hospital were not inconsistent with one Australian point-prevalence study where, 
despite disappointing low levels of EOL form completion rates, public hospitals were 
statistically more likely to complete EOL documentation than in private hospitals (16.7 vs 7.1%, 
P < 0.001).5 Factors contributing to the reluctance of healthcare providers to broach EOL have 
been previously well described and remain difficult to address.24,25 Strategies to improve GOC 
discussion need to be multifaceted, incorporating greater postgraduate education, the 
inclusion of GOC documentation on ward rounds and clinical handover (attempted in this 
study), and specific physician reimbursement for EOL discussions (recently introduced in the 
USA). Ultimately, any successful strategy will necessitate a top-down approach with strong 
clinical leadership from senior clinicians and healthcare administrators. Finally, the high 
incompletion rate of the GOC form, particularly the important patient preference 
documentation, suggests a design review may be pertinent. 
Limitations 
As a single centre, non-randomised study deliberately restricted to wards with known high-
degrees of disease burden and frailty, the generalisability of our findings may be limited to 
other speciality wards. Perhaps the biggest limitation was not being able to mandate the use 
of the GOC form for every patient during the intervention arm of the study. It is the authors 
opinion that without the widespread cultural shift in EOL discussions then the GOC confers 
only a few advantages over the NFR form and represents a real challenge for its wider 
application. It may also be that within the time constraints of a busy private practice 
specialist-patient discussions are occurring but not being documented. While these 
limitations reflect a real-world practicality, it was clinically disappointing given the private 
health system fosters a much greater specialist-patient continuity than in the public health 
system. Furthermore, there is a lack of internationally recognised outcome measures when 
researching EOL documentation. Finally, the initiation of treatment limitations is often a 
complex mixing of medical, psycho-social, cultural and personal factors that are not easily 
quantified. Beyond the scope of a single manuscript, this study also incorporated a detailed 
qualitative component with the intention of publishing this data as a separate manuscript. 
Conclusion 
EOL decision making remains a challenging component of modern healthcare. In cohort 
patients with a high burden of comorbid disease an increased uptake of the GOC form was 
achieved. However, the overall GOC form uptake remained well below previously reported 
rates, written GOC form completion was poor, and nearly all quantitative outcomes remained 
statistically unchanged. Further research is required before a wider rollout of the GOC form 
can be supported in Australia’s private healthcare systems. 
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Table 1  
1. Baseline characteristics comparing the not-for-resuscitation (control) and goals-of-care 
(intervention) phases over two separate, corresponding six-month periods. 
Characteristic NFR Phase* (n=650) GOC Phase† (n=653) P 
Age - years,  
Mean [SD, median, IQR] 
70.9  
[13.8; 72.8; 64 – 80] 
70.4 
[14.0, 72, 62 – 80] 
0.51 
Gender – female, n (%) 385 (59.2%) 396 (60.6) 0.27 
Primary speciality‡, n (%)   0.23 
Oncology 293 (45.1) 317 (48.5)  
Haematology 47 (7.2) 37 (5.7)  
Palliative care  35 (5.4) 36 (5.5)  
Internal medicine 109 (16.8) 82 (12.6)  
Respiratory medicine 81 (12.5) 100 (15.3)  
Gerontology 58 (8.9) 56 (8.6)  
Other medical specialties§ 27 (4.1) 25 (3.8)  
Charlson Comorbity Index 
Mean [SD, median, IQR] 
   
Standard 3.73 [2.72; 4; 1 – 6]  3.66 [2.58, 3, 2 – 6] 0.99 
Age adjusted 6.30 [2.89; 6; 4 – 9]  6.26 [2.83, 6, 4 – 9] 0.72 
Main Diagnosis‡, n (%)    
Malignant disease   0.32 
Solid cancer – no metastatic 
disease 
119 (18.3) 114 (17.5)  
Solid cancer – with metastatic 
disease 
222 (34.2) 256 (39.2)  
Haematological cancer 45 (6.9) 39 (6.0)  
Non-malignant disease   < 0.001 
Heart disease 16 (2.5) 6 (0.9)  
Respiratory disease 84 (12.9) 110 (16.8)  
Kidney disease 9 (1.4) 2 (0.3)  
Liver disease 1 (0.2) 0 (0.0)  
Neurological disease 15 (2.3) 21 (3.2)  
Excessive age / frailty 60 (9.2) 78 (11.9)  
Other diseases 79 (12.2) 27 (4.1)  
Number of Admissions, n (%)   0.24 
1 Hospitalisation 484 (74.4) 466 (71.4)  
2 Hospitalisations 109 (16.8) 112 (17.1)  
> 2 Hospitalisations 57 (8.8) 75 (11.5)  
Hospitalisation LOS - days, mean [SD, 
median, IQR] 
8.7 
[10.1; 5.9; 3 – 10] 
9.0 
[9.6, 5.9, 3 – 10] 
0.48 
NFR = not-for-resuscitation form. GOC = goals-of-care form, SD = standard deviation, IQR = interquartile range, LOS = 
length-of-stay. 
* NFR period March – August 2016. † GOC period March – August 2017. ‡ First medical specialty admitted under in the 
observation period. § Includes infectious disease, nephrology, neurology, gastroenterology, cardiology and rheumatology. 
 
     
 
 
 
Table 2  
2. Treatment level-of-care, end-of-life documentation, acute and palliative care resource 
consumption, and mortality outcomes comparing the not-for-resuscitation (control) and goals-
of-care (intervention) groups based on the number of hospital admissions over two separate, 
corresponding six-month periods. 
Characteristic NFR Phase* (n=905) GOC Phase† (n=990) P 
Final treatment level-of-care‡, n (%)    
Full resuscitation (undocumented) 769 (85.0) 649 (65.6) < 0.001 
Full resuscitation (documented) 0 (0.0) 131 (13.2) < 0.001 
ICU with limitations 12 (1.3) 51 (5.1) < 0.001 
Ward level care with RRT activation 22 (2.4) 52 (5.3) 0.001 
Palliative level ward care 102 (11.3) 107 (10.8) 0.77 
End-of-Life documentation    
Absolute number of completed EOL 
forms, n (%) 
136 (15.0) 341 (34.4)  
EOL uptake rate, per 1000 
hospitalisations [95%CI] 
150.3 
[126.6 – 177.2] 
344.4 
[309.3 – 382.5] 
< 0.001 
EOL uptake rate – excluding full 
resuscitation (Goal A), per 1000 
hospitalisations [95%CI] 
150.3 
[126.6 – 177.2] 
212.1 
[184.9 – 242.3] 
0.002 
Rapid response team    
Absolute number of RRT activations, n 70 74  
RRT activation rate, per 1000 
hospitalisations [95%CI] 
77.3  
[60.8 – 97.1] 
72.8 
[57.4 – 91.2] 
0.72 
Number of hospitalisations with 
multiple RRT activations, n (%) 
13 (1.4) 12 (1.2) 0.69 
Intensive or coronary care    
Absolute number of ICU or CCU 
admissions, n (%) 
20 (2.2) 18 (1.8)  
ICU or CCU admissions rate, per 1000 
hospitalisations [95%CI] 
22.1 
[13.9 – 33.5] 
18.2 
[10.8 – 28.7] 
0.55 
Palliative care admissions    
Absolute number of palliative care 
admissions, n (%) 
35 (3.9) 36 (3.6)  
Palliative care admission rate, per 
1000 hospitalisations [95%CI] 
38.7 
[26.9 – 53.8] 
36.4  
[25.5 – 50.3] 
0.80 
Mortality    
Total In-hospital, n (%) 78 (12.0) 83 (12.7)  
In-hospital rate, per 1000 
hospitalisations [95%CI] 
86.2 
[68.6 – 107.0] 
83.8 
[66.4 – 102.4] 
0.86 
NFR = not-for-resuscitation, GOG = goals-of-care, ICU = intensive care unit, EOL = end-of-life, CI = confidence intervals, RRT 
= rapid response team, CCU = coronary care unit. 
* NFR period March – August 2016. † GOC period March – August 2017. ‡ Final EOL form level-of-care. Where written 
documentation did not exist, full resuscitation was the assumed level-of-care. 
 
 
 
 
 
Table 3  
3. Outcome comparisons between hospitalisations with at least one completed NFR (control) or 
GOC (intervention) form over separate, corresponding six-month periods. 
Characteristic NFR Phase* (n=136) GOC Phase† (n=341) P 
Age - years,  
Mean [SD, median, IQR] 
73.1  
[13.2, 75.3, 66 – 82] 
72.3 
[13.3, 72.6, 65 – 82] 
0.55 
Gender – female, n (%) 68 (50.0) 202 (59.2) 0.08 
Hospital LOS - days,  
mean [SD, median, IQR] 
   
All admissions with an EOL form 16.6  
[15.9, 13.5, 7 – 20] 
11.9  
[10.8, 8.2, 5 – 15] 
< 0.001 
Admissions with limitation-in-
treatment EOL form‡ 
16.6  
[15.9, 13.5, 7 – 21] 
14.5  
[12.1, 10.1, 6 – 20] 
0.12 
Primary speciality§, n (%)   < 0.001 
Onco-haematology 82 (60.3) 143 (41.9)  
Medical specialties 26 (19.2) 152 (44.4)  
Palliative care 28 (20.5) 46 (13.5)  
Final documented treatment level-of-
care‡, n (%) 
  < 0.001 
Full resuscitation 0 (0) 131 (38.4)  
ICU with limitations 12 (8.8) 51 (15.0)  
Ward level care with RRT activation 22 (16.2) 52 (15.2)  
Palliative level care 102 (75.0) 107 (31.4)  
Number of EOL forms per 
hospitalisation¶, n (%) 
  0.86 
1 EOL Form 120 (89.0) 300 (88.0)  
2 EOL Forms 14 (10.3) 40 (11.7)  
3 EOL Forms 1 (0.7) 1 (0.3)  
4 EOL Forms 1 (0.7) 0 (0.0)  
Hospitalisations where the EOL form 
level-of-care was altered, per 1000 
hospitalisations [95%CI] 
17.7 
[10.1 – 28.7] 
41.4  
[29.7 – 56.2] 
0.003 
EOL Documentation Timing    
First EOL form completed within 48 
hours of hospital admission, n (%) 
53 (39.0) 198 (58.1) < 0.001 
Final EOL completed by non-consultant 
staff, n (%) 
46 (33.8) 126 (36.9) 0.34 
EOL form completed outside of normal 
office hours**, n (%) 
54 (33.8) 107 (28.1) 0.12 
EOL form completed within 24-hours 
of a RRT activation††, n  
12 (1.3) 11 (1.1) 0.68 
Time between admission to hospital 
and first treatment limitation EOL 
order completed – days‡, mean [SD, 
median, IQR] 
5.9 
[7.9, 3.0, 0.3 – 8] 
4.6 
[6.4, 1.6, 0.2 – 7] 
0.09 
Hospitalisations where the EOL form was 
rescinded or de-escalated, n (%) 
0 (0) 0 (0)  
NFR = not-for-resuscitation form. GOC = goals-of-care form, LOS = length-of-stay, ICU = intensive care unit, EOL = end-of-
life, SD = standard deviation, IQR = interquartile range, RRT = rapid response team. 
* NFR period March – August 2016. † GOC period March – August 2017. ‡ Excludes 131 full resuscitation orders in the 
GOC group. § Final documented EOL form level-of-care. ¶ Multiples of EOL forms include either new or substantially 
altered EOL forms where a change in the ceiling-of-treatment occurred. ** Based on all EOL forms (NFR=154, GOC=381) 
completed during the study period. Outside of normal office hours = 18:00 - 08:00 Monday to Friday and all weekends. 
†† Based on total number of admissions.  
 4. Relationship between all in-hospital deaths, the timing of hospital admission, and the use of 
end-of-life forms during both six-month periods. 
Characteristic NFR Phase*  GOC Phase†  P 
Number of in-hospital deaths 78 83  
Time between admission and in-hospital 
death - days, 
mean [SD, median, IQR] 
14.8 
[12.5, 11.7, 6 – 20] 
16.4  
[13.6, 13.6, 6 – 24] 
0.44 
Relationship between EOL form 
documentation and in-hospital death 
   
Number of in-hospital deaths with prior 
EOL form completion, n (%) 
75 (96.2) 74 (89.2) 0.13 
Time between admission and first EOL 
form completion - days, mean [SD, 
median, IQR] 
6.9 
[8.2, 3.9, 0.7 – 10] 
5.2 
[7.1, 1.9, 0.2 – 7] 
0.07 
Time between final EOL form 
completion and in-hospital death - days, 
mean [SD, median, IQR] 
7.7  
[8.4, 4.9, 1.6 – 11.6] 
8.2 
[8.8, 5.6, 1.8- 11.5] 
0.80 
Number of EOL forms first completed 
within 48 hours of death‡, n (%) 
23 (29.5) 29 (34.9) 0.50 
NFR = not-for-resuscitation Form. GOC = goals-of-care Form. SD = standard deviation, IQR = interquartile range, EOL = 
end-of-life. 
* NFR period March – August 2016. † GOC period March – August 2017. ‡ Includes patients with no EOL documentation 
 
  
5. In-hospital end-of-life documentation and subsequent short-term mortality between 1st 
March – 31st December in 2016 (NFR) and 2017 (GOC) with minimum 4-month follow up. 
Characteristic NFR Phase* (n=650) GOC Phase† (n=653) P 
Follow up time - entire cohort‡, 
days, mean [SD, median, IQR] 
186.7  
[87.6, 201.4, 136 – 257] 
176.1  
[86.8, 185.5, 121 – 249] 
0.03 
Number of deaths to 31st 
December 2016/17 
   
Total deaths, n (%) 191 (29.4) 199 (30.5) 0.67 
Time between first admission 
and death by 31st December 
2016/17 – days, mean [SD, 
median, IQR] 
65.0 
[70.0, 33.4, 14 – 109] 
49.3 
[49.2, 35.7, 14 – 67] 
0.35 
Number of deaths with prior in-
hospital EOL documentation 
   
Number of deaths with any 
prior in-hospital EOL form 
completed, n (%) 
105 (55.0) 124 (62.3)‡ 0.15 
Number of deaths with prior 
documented limitations-in-
therapy (Goal B, C or D)§, n (%) 
105 (55.0) 119 (59.8) 0.36 
Number of deaths with prior 
documented palliative (Goal D) 
limitations-in-therapy 
88 (46.1) 88 (44.2) 0.76 
Time between final EOL form 
and death – days, mean [SD, 
median, IQR] 
23.7 
[46.7, 9.7, 4 – 20] 
30.7 
[41.8, 11.7, 4 – 42] 
0.21 
NFR = not-for-resuscitation form. GOC = goals-of-care form, SD = standard deviation, IQR = interquartile 
range, EOL = end-of-life. 
* NFR period March – August 2016. † GOC period March – August 2017. ‡ Includes five Goal A – full 
resuscitation EOL § From initial admission date and excludes EOL with full resuscitation (Goal A). NFR n=650 
patients, GOC n=653. 
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eTable 1. The written completion rate of significant GOC form sub-sections by clinical staff 
 
 
 
 
 
 
Full resuscitation 
Goal A 
(n = 131) 
Limitations in treatment  
Goals B, C or D 
(n = 210) 
All treatment levels 
Goals A, B, C or D 
 (n = 341) 
GOC 
Section 
Completed 
GOC 
Section 
Not 
Completed 
GOC 
Section 
Completed 
GOC 
Section 
Not 
Completed 
GOC 
Section 
Completed 
GOC 
Section 
Not 
Completed 
Consultant 
review, n (%) 
104 (79.4) 27 (20.6) 176 (83.8) 34 (16.2) 280 (82.1) 61 (17.9) 
Primary 
disease, n (%) 
4 (3.1) 127 (96.9) 84 (40.0) 126 (60.0) 88 (25.8) 253 (74.2) 
Advanced 
health 
directive, n 
(%) 
1 (0.8) 130 (99.2) 43 (20.5) 167 (79.5) 44 (12.9) 297 (87.1) 
GOC 
discussion 
with patient, 
n (%) 
3 (2.3) 128 (97.7) 76 (36.2) 134 (63.8) 79 (23.2) 262 (76.8) 
GOC 
discussion 
with NOK, n 
(%) 
2 (1.5) 129 (98.5) 76 (36.2) 134 (63.8) 78 (22.9) 263 (77.1) 
Medial 
assessment, n 
(%) 
2 (1.5) 129 (98.5) 67 (31.9) 143 (68.1) 69 (21.2) 272 (79.8) 
Mental 
capacity 
assessment, n 
(%) 
2 (1.5) 129 (98.5) 62 (29.5) 148 (70.5) 64 (18.8) 277 (81.2) 
Patient 
preferences, 
n (%) 
2 (1.5) 129 (98.5) 56 (26.7) 154 (73.3) 58 (17.0) 283 (83.0) 
Decision 
rationale, n 
(%) 
2 (1.5) 129 (98.5) 73 (34.8) 137 (65.2) 75 (22.0) 266 (78.0) 
GOC = goals-of-care,  
 
 
